KNTE
Kinnate Biopharma Inc
Price:  
2.65 
USD
Volume:  
2,812,220.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KNTE Relative Valuation

-2048.8%
Upside

As of 2025-07-07, the Relative Valuation of Kinnate Biopharma Inc (KNTE) is (51.64) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.65 USD, the upside of Kinnate Biopharma Inc based on Relative Valuation is -2048.8%.

The range of the Relative Valuation is (32.72) - (64.48) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.1x - 27.0x 20.0x
Forward P/E multiples 13.7x - 32.7x 23.2x
Fair Price (32.72) - (64.48) (51.64)
Upside -1334.6% - -2533.2% -2048.8%
2.65 USD
Stock Price
(51.64) USD
Fair Price

KNTE Relative Valuation - Historical P/E Data

Date P/E